FDA inspection
Zhejiang Haisen Pharmaceutical Co., Ltd.: FDA inspection ending Dec 12, 2014
FDA inspection 910004 · No Action Indicated (NAI) · Dongyang
Key facts
| Inspection ID | 910004 |
|---|---|
| Firm | Zhejiang Haisen Pharmaceutical Co., Ltd. |
| FEI number | 3003967524 |
| Address | Xiangtan Village, Liushi Shequ |
| City | Dongyang |
| Country | China |
| Fiscal year | 2015 |
| Inspection end date | Dec 12, 2014 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data